Steen Riisgaard is a Danish businessperson who has been the head of 12 different companies. Currently, he is Chairman of New Xellia Group A.
He is also on the board of 6 other companies.
In the past Mr. Riisgaard held the position of Chairman at Rockwool International A, Chairman of ALK-Abello A, Chairman for World Wildlife Fund Denmark, Chairman for Xellia Pharmaceuticals ApS, Chairman of Egmont (Denmark), President & Chief Executive Officer of Novozymes A, Executive Vice President-Enzyme Business at Novo Nordisk A, Research Microbiologist at Foss Electric Holding, Principal at Novo Industri Japan Ltd., Chairman of COWI A, Chairman for COWI Holding A, Chairman for Egmont Fonden and Principal at Statens Serum Institute.
Mr. Riisgaard received a graduate degree from the University of Copenhagen.